Company intelligence / Profile preview

Laser Tissue Welding

Humble, Texas, United Stateslasertissuewelding.com ↗

Ownership: Private
Development stage: Other

Overview

Laser Tissue Welding’s technology is a novel combination of a diode laser and human serum albumin-based biomaterials designed to instantly seal hemorrhages and fluid leaks during surgery without burning. It is particularly aimed at enabling interventions on vascular organs even in the presence of coagulation failure. The system has not yet received FDA approval for general use.

Therapeutic areas: Hematology
Modalities: DeviceBiologic (human serum albumin-based surgical sealant)
Industry: Surgical Medical Devices

Partnerships

NIH Commercialization Assistance Program participant; no major pharma or biotech partnerships disclosed publicly as of latest available data

Beyond the preview

Go deeper on Laser Tissue Welding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laser Tissue Welding.

Explore the full profile